Value through Innovation

main navigation

jump to contentto meta navigation
Chronic Obstructive Pulmonary Disease (COPD)

page content

jump to main navigationto meta navigation

Chronic Obstructive Pulmonary Disease (COPD) News and Information

This section includes information and resources about Chronic Obstructive Pulmonary Disease (COPD) for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.

COPD Press Releases

27.09.2011 European Respiratory Society (ERS) Awards Annual COPD Research Prize
21.09.2011 Boehringer Ingelheim enrols first patient in Phase III program for new once-daily fixed-dose combination of tiotropium plus olodaterol in COPD - For Media outside the U.S. and Canada
15.06.2011 Boehringer Ingelheim/Pfizer position regarding the recent publication by Singh et. al., in British Medical Journal, June 15, 2011 - For non-US Healthcare Media
23.03.2011 The POET-COPD® study results demonstrate superiority of Spiriva® (tiotropium) over long-acting beta agonist salmeterol in reducing the risk for COPD exacerbations - For medical media outside the USA and Canada
20.09.2010 ERS COPD Research Award 2010
Sponsored by Boehringer Ingelheim - For medical media outside the US only

COPD Video Gallery

  • COPD Patient Video
    Living with COPD

    Patients with different backgrounds describe their life with COPD.

  • What is POET-COPD?
    Prof. Dr Claus Vogelmeier

    POET-COPD®

  • What are COPD Exacerbations?

      
    Prof. Dr Claus Vogelmeier

    COPD Exacerbations

back to top

Media Contact

Media Contact
Our media contacts

Other News & Press Releases

boehringer-ingelheim.com

Boehringer Ingelheim offers an optimized solution for mobile devices
Solution for mobile devices

News & Press Releases

News